This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Kyowa Hakko Bio Co., Ltd., Kyowa Hakko Kogyo Co., Ltd., Mitsubishi Gas Chemical Company, Inc.. Active years: 2009-2012.
Location History:
- Tsukuba, JP (2009)
- Ibaraki, JP (2012)
Company Filing History:
1 out of 104 
1 out of 730 
1 out of 2,300 
Years Active: 2009-2012
Title: Fumiko Ogino: Innovator in Diabetes Treatment
Introduction
Fumiko Ogino is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of diabetes treatment, particularly in developing agents that improve insulin resistance. With a total of 2 patents, her work is recognized for its potential impact on managing type II diabetes.
Latest Patents
Ogino's latest patents include an insulin resistance improving agent aimed at providing a safe and effective therapeutic solution for type II diabetes. This invention comprises a compound represented by a specific general formula, which includes various chemical structures. Additionally, she has developed a therapeutic agent for diabetes mellitus that includes hydroxyproline or its derivatives, which can be used in foods, drinks, and feed additives to treat diabetes and improve insulin resistance.
Career Highlights
Throughout her career, Fumiko Ogino has worked with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Bio Co., Ltd. Her innovative research and development efforts have positioned her as a key figure in the pharmaceutical industry, particularly in the area of diabetes treatment.
Collaborations
Ogino has collaborated with esteemed colleagues, including Toshikazu Kamiya and Akio Shirai, to advance her research and develop effective therapeutic agents.
Conclusion
Fumiko Ogino's contributions to diabetes treatment through her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in managing insulin resistance and diabetes.